{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:14:30Z","timestamp":1790957670622,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["bjanaesthesia.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["British Journal of Anaesthesia"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.bja.2020.04.089","type":"journal-article","created":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T21:21:39Z","timestamp":1592947299000},"page":"133-140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Availability of dantrolene for the management of malignant hyperthermia crises: European Malignant Hyperthermia Group guidelines"],"prefix":"10.1016","volume":"125","author":[{"given":"Klaus P.E.","family":"Glahn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Bendixen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Girard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip M.","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Johannsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"R\u00fcffert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc M.","family":"Snoeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Urwyler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bja.2020.04.089_bib1","first-page":"700","article-title":"Incidence of malignant hyperthermia in Denmark","volume":"64","author":"Ording","year":"1985","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bja.2020.04.089_bib2","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1001\/jama.293.23.2918","article-title":"Malignant hyperthermia: update on susceptibility testing","volume":"293","author":"Litman","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.bja.2020.04.089_bib3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1750-1172-2-21","article-title":"Malignant hyperthermia","volume":"2","author":"Rosenberg","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.bja.2020.04.089_bib4","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/ALN.0b013e318190bb08","article-title":"Trends and outcomes of malignant hyperthermia in the United States, 2000 to 2005","volume":"110","author":"Rosero","year":"2009","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2020.04.089_bib5","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/ALN.0b013e3181ca7c38","article-title":"Case scenario: increased end-tidal carbon dioxide: a diagnostic dilemma","volume":"112","author":"Tautz","year":"2010","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2020.04.089_bib6","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1213\/ANE.0b013e3182937d8b","article-title":"Malignant hyperthermia in Canada: characteristics of index anesthetics in 129 malignant hyperthermia susceptible probands","volume":"118","author":"Riazi","year":"2014","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bja.2020.04.089_bib7","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1213\/ANE.0b013e3181c6b9b2","article-title":"Clinical presentation, treatment, and complications of malignant hyperthermia in North America from 1987 to 2006","volume":"110","author":"Larach","year":"2010","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bja.2020.04.089_bib8","series-title":"Dantrium intravenous: summary of product characteristics","year":"2019"},{"key":"10.1016\/j.bja.2020.04.089_bib9","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/bja\/aeq243","article-title":"Recognizing and managing a malignant hyperthermia crisis: guidelines from the European Malignant Hyperthermia Group","volume":"105","author":"Glahn","year":"2010","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2020.04.089_bib10","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/bjaed\/mkw079","article-title":"Diagnosis and management of malignant hyperthermia","volume":"17","author":"Gupta","year":"2017","journal-title":"BJA Educ"},{"key":"10.1016\/j.bja.2020.04.089_bib11","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s12630-018-1108-0","article-title":"Updated guide for the management of malignant hyperthermia","volume":"65","author":"Riazi","year":"2018","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.bja.2020.04.089_bib12","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1097\/ALN.0000000000000257","article-title":"Cost-effectiveness analysis of stocking dantrolene in ambulatory surgery centers for the treatment of malignant hyperthermia","volume":"120","author":"Aderibigbe","year":"2014","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2020.04.089_bib13","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1213\/ANE.0000000000001682","article-title":"Society for Ambulatory Anesthesia (SAMBA): succinylcholine for emergency airway rescue in class B ambulatory facilities: the Society for Ambulatory Anesthesia position statement","volume":"124","author":"Joshi","year":"2017","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bja.2020.04.089_bib14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/ALN.0000000000002490","article-title":"Succinylcholine use and dantrolene availability for malignant hyperthermia treatment: database analyses and systematic review","volume":"130","author":"Larach","year":"2019","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2020.04.089_bib15","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/ALN.0000000000002507","article-title":"Succinylcholine and dantrolene\u2014inseparable in the emergency cupboard?","volume":"130","author":"Hopkins","year":"2019","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2020.04.089_bib16","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1213\/ANE.0000000000004039","article-title":"Consensus statement of the Malignant Hyperthermia Association of the United States on unresolved clinical questions concerning the management of patients with malignant hyperthermia","volume":"128","author":"Litman","year":"2019","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bja.2020.04.089_bib17","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/bja\/aer132","article-title":"Malignant hyperthermia: pharmacology of triggering","volume":"107","author":"Hopkins","year":"2011","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2020.04.089_bib18","doi-asserted-by":"crossref","first-page":"i1152","DOI":"10.1136\/bmj.i1152","article-title":"The AGREE Reporting Checklist: a tool to improve reporting of clinical practice guidelines","volume":"352","author":"Brouwers","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.bja.2020.04.089_bib19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bja.2019.02.029","article-title":"Consensus clinical scoring for suspected perioperative immediate hypersensitivity reactions","volume":"123","author":"Hopkins","year":"2019","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2020.04.089_bib20","series-title":"The RAND\/UCLA appropriateness method User\u2019s Manual","author":"Fitch","year":"2001"},{"key":"10.1016\/j.bja.2020.04.089_bib21","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.bja.2020.04.089_bib22","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.bja.2019.04.044","article-title":"Management of suspected immediate perioperative allergic reactions: an international overview and consensus recommendations","volume":"123","author":"Garvey","year":"2019","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2020.04.089_bib23","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/bja\/60.3.279","article-title":"Malignant hyperthermia. Dantrolene\u2014dynamics and kinetics","volume":"60","author":"Harrison","year":"1988","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2020.04.089_bib24","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1213\/01.ANE.0000184184.40504.F3","article-title":"Compartmental pharmacokinetics of dantrolene in adults: do malignant hyperthermia association dosing guidelines work?","volume":"101","author":"Podranski","year":"2005","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bja.2020.04.089_bib25","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/bja\/47.1.62","article-title":"Control of the malignant hyperpyrexic syndrome in MHS swine by dantrolene sodium","volume":"47","author":"Harrison","year":"1975","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2020.04.089_bib26","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/00000542-198004000-00003","article-title":"Dantrolene dose response in malignant hyperthermia-susceptible (MHS) swine: method to obtain prophylaxis and therapeusis","volume":"52","author":"Flewellen","year":"1980","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2020.04.089_bib27","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00000542-198310000-00002","article-title":"Dantrolene dose response in awake man: implications for management of malignant hyperthermia","volume":"59","author":"Flewellen","year":"1983","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2020.04.089_bib28","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/00000542-197911000-00016","article-title":"Recrudescence after survival of an initial episode of malignant hyperthermia","volume":"51","author":"Mathieu","year":"1979","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2020.04.089_bib29","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/01.anes.0000265148.86566.68","article-title":"Analysis of the clinical variables associated with recrudescence after malignant hyperthermia reaction","volume":"106","author":"Burkman","year":"2007","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2020.04.089_bib30","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1097\/01.anes.0000265144.63696.af","article-title":"Recrudescence of malignant hyperthermia","volume":"106","author":"Hopkins","year":"2007","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2020.04.089_bib31","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF03011484","article-title":"Dantrolene","volume":"31","author":"Britt","year":"1984","journal-title":"Can Anaesth Soc J"},{"key":"10.1016\/j.bja.2020.04.089_bib32","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1213\/ANE.0b013e31820b5f1f","article-title":"Complications associated with the administration of dantrolene 1987 to 2006: a report from the North American Malignant Hyperthermia Registry of the Malignant Hyperthermia Association of the United States","volume":"112","author":"Brandom","year":"2011","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bja.2020.04.089_bib33","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jclinane.2013.02.004","article-title":"Upper extremity deep vein thrombosis in a patient treated for malignant hyperthermia","volume":"25","author":"Grodofsky","year":"2013","journal-title":"J\u00a0Clin Anesth"},{"key":"10.1016\/j.bja.2020.04.089_bib34","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/00000542-198904000-00013","article-title":"Pharmacokinetics of intravenous dantrolene in children","volume":"70","author":"Lerman","year":"1989","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2020.04.089_bib35","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1213\/ANE.0b013e31826f5e3b","article-title":"Estimate of the relative risk of succinylcholine for triggering malignant hyperthermia","volume":"116","author":"Dexter","year":"2013","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bja.2020.04.089_bib36","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/ALN.0000000000002231","article-title":"Cost-benefit analysis of maintaining a fully stocked malignant hyperthermia cart versus an initial dantrolene treatment dose for maternity units","volume":"129","author":"Ho","year":"2018","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2020.04.089_bib37","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/ALN.0000000000002279","article-title":"Dantrolene and malignant hyperthermia carts: do we need them on maternity units?","volume":"129","author":"Wong","year":"2018","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2020.04.089_bib38","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s00101-017-0335-z","article-title":"Stocks of dantrolene in anesthesia and intensive care units in Germany: nationwide online survey with 1673 participants","volume":"66","author":"Pfenninger","year":"2017","journal-title":"Anaesthesist"},{"key":"10.1016\/j.bja.2020.04.089_bib39","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00063-018-0453-7","article-title":"Inhalational analgosedation in the intensive care unit: risk of malignant hyperthermia","volume":"115","author":"Klingler","year":"2020","journal-title":"Med Klin Intensivmed Notfmed"},{"key":"10.1016\/j.bja.2020.04.089_bib40","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2253-13-24","article-title":"Evaluation of suspected malignant hyperthermia events during anesthesia","volume":"13","author":"Schuster","year":"2013","journal-title":"BMC Anesthesiol"},{"key":"10.1016\/j.bja.2020.04.089_bib41","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1750-1172-9-8","article-title":"Functional and genetic characterization of clinical malignant hyperthermia crises: a multi-centre study","volume":"9","author":"Klingler","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.bja.2020.04.089_bib42","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.bjan.2018.09.007","article-title":"Perfil dos relatos de suscetibilidade \u00e0 hipertermia maligna confirmados com teste de contratura muscular no Brasil","volume":"69","author":"Almeida da Silva","year":"2019","journal-title":"Rev Bras Anestesiol"},{"key":"10.1016\/j.bja.2020.04.089_bib43","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00101-018-0419-4","article-title":"Abortiver Verlauf einer Malignen Hyperthermie nach pr\u00e4klinischer Narkoseinduktion mit Succinylcholin","volume":"67","author":"Helf","year":"2018","journal-title":"Anaesthesist"},{"key":"10.1016\/j.bja.2020.04.089_bib44","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/0310057X1504300415","article-title":"The changing face of malignant hyperthermia: less fulminant, more insidious","volume":"43","author":"Heytens","year":"2015","journal-title":"Anaesth Intensive Care"},{"key":"10.1016\/j.bja.2020.04.089_bib45","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1213\/ANE.0000000000004399","article-title":"Dantrolene should be readily available wherever malignant hyperthermia triggering drugs are stocked","volume":"129","author":"Larach","year":"2019","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bja.2020.04.089_bib46","first-page":"251","article-title":"Malignant hyperthermia in a morbidly obese patient depletes community dantrolene resources: a case report","volume":"9","author":"Magistris","year":"2017","journal-title":"A\u00a0A Case Rep"}],"container-title":["British Journal of Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091220303494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091220303494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T18:56:19Z","timestamp":1757789779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007091220303494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S0007091220303494"],"URL":"https:\/\/doi.org\/10.1016\/j.bja.2020.04.089","relation":{},"ISSN":["0007-0912"],"issn-type":[{"value":"0007-0912","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Availability of dantrolene for the management of malignant hyperthermia crises: European Malignant Hyperthermia Group guidelines","name":"articletitle","label":"Article Title"},{"value":"British Journal of Anaesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bja.2020.04.089","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 British Journal of Anaesthesia. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}